Here, genetic and pharmacologic (UCM-1336) ICMT inhibition suppressed proliferation and invasion in BRAF<sup>V600E</sup>-mutant melanoma cells and reduced tumor growth in xenografts and mice. The gene discussed is BRAF; the disease is melanoma.